The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
30
No.
46
December 10, 2004
- ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.
- Also NCI prostate SPOREs plan biospecimen bank.
- NCI advisors seek comment on clinical trials system, until Jan. 15.
- NCI funds 17 EDRN biomarker labs. Bush signs omnibus funding legislation.
- Dept. of Defense opens program announcements for prostate cancer research.
- Children’s Cancer Research Institute at UT Health Science Center recruits faculty.
- Two cancer center directors named: Michael Kastan at St. Jude, James Willson at Harold Simmons.
- December issue of Business & Regulatory Report included (an additional 8 pages of industry news).
- Next issue of The Cancer Letter is scheduled for Jan. 7, 2005.
CCL
Vol.
27
No.
12
December 31, 2004
- New Treatment Approaches for Leukemias Emerging From Early Clinical Trials
- New Test Predicts Breast Cancer Recurrence And Who Benefits Most From Chemotherapy
- Genasense Added To Chemo Improves Responses in CLL
- Blacks, Whites Have Same Contralateral Breast Cancer Risk While On Tamoxifen
- Of Smokers Screened With CT In Study, 7% Have Lung Cancer
- Insulin For Diabetes Increases Risk Of Colorectal Cancer
- NCI-Approved Clinical Trials